Antibody-drug conjugate (ADC) specialists Adcendo and Duality Biologics have expanded an existing collaboration to develop ADCs, just a few months after they st 30 May 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.